Literature DB >> 32026769

Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications.

Md Abul Barkat1, Sabya S Das2, Faheem H Pottoo3, Sarwar Beg4, Ziyaur Rahman5.   

Abstract

The contemporary drug discovery research shows that most of the drug candidates are highly potent, but showing poor aqueous solubility leads a variety of challenges for formulation scientists to develop a suitable formulation to improve the systemic bioavailability of such drugs. Lipid-based nanocarriers act as a major and most projecting approach overcoming the limitations which affect several physiochemical properties of drug such as the solubility, partition coefficient and bioavailability or absorption. This also fulfills a variety of product requirements and helps to overcome several limitations as decided by symptoms of the disease, various routes of administration of drug, price concern, increasing strength of product, noxious or harmful effect of drug, and dose efficacy. The lipidic nanosystem formulates aqueous drug in lipid base and is also a commercially feasible approach for the formulation of different dosage forms meant for topical or transdermal, oral, ocular, pulmonary, and parenteral delivery. This review provides a brief on lipid-based drug delivery nanocarrier and the mechanisms by which lipids and lipidic excipients improve the oral absorption of drugs with poor aqueous solubility and also provide a viewpoint on the promising applications of lipidic nanoparticulate systems. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Keywords:  Drug discovery; aqueous drug; bioavailability; lipid-based nanocarriers; physiochemical properties; poor aqueous solubility.

Mesh:

Substances:

Year:  2020        PMID: 32026769     DOI: 10.2174/1381612826666200206094529

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Systematic Development of Solid Lipid Nanoparticles of Abiraterone Acetate with Improved Oral Bioavailability and Anticancer Activity for Prostate Carcinoma Treatment.

Authors:  Sarwar Beg; Ankit K Malik; Mohammad Javed Ansari; Asrar A Malik; Ahmed Mahmoud Abdelhaleem Ali; Abdulrahman Theyab; Mohammad Algahtani; Waleed H Almalki; Khalid S Alharbi; Sattam K Alenezi; Md Abul Barkat; Mahfoozur Rahman; Hani Choudhry
Journal:  ACS Omega       Date:  2022-05-10

Review 2.  Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications.

Authors:  Bazla Siddiqui; Asim Ur Rehman; Ihsan-Ul Haq; Amal A Al-Dossary; Abdelhamid Elaissari; Naveed Ahmed
Journal:  Int J Pharm X       Date:  2022-04-19

Review 3.  Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin.

Authors:  Yukun Chen; Zhenzhi Wang; Xiaofan Wang; Mingliang Su; Fan Xu; Lian Yang; Lijun Jia; Zhanxia Zhang
Journal:  Int J Nanomedicine       Date:  2022-09-14

4.  Crystal Growth and Kinetic Behaviour of Pseudoalteromonas espejiana Assisted Biosynthesized Gold Nanoparticles.

Authors:  Rashmi Gupta; Gourav Kumar; Sabya Sachi Das; Saad Alkahtani; Abdullah Alkahtane; Badr Aldahmash; Saud Alarifi; Bader Almutairi; Gadah Albasher; Amit Kumar Nayak; Md Saquib Hasnain
Journal:  Oxid Med Cell Longev       Date:  2020-08-03       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.